These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 19546522

  • 1. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA.
    Dermatology; 2009; 219(2):126-32. PubMed ID: 19546522
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M, Chams-Davatchi C, Hemami MR, Fateh S.
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [Abstract] [Full Text] [Related]

  • 3. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
    Geilen CC, Arnold M, Orfanos CE.
    Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
    [Abstract] [Full Text] [Related]

  • 5. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.
    Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
    Zhou Y, Rosenthal D, Dutz J, Ho V.
    J Cutan Med Surg; 2003 Jan; 7(3):193-7. PubMed ID: 12704533
    [Abstract] [Full Text] [Related]

  • 7. Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study.
    Colombo D, Cassano N, Altomare G, Giannetti A, Vena GA.
    Int J Immunopathol Pharmacol; 2010 Jan; 23(4):1143-52. PubMed ID: 21244763
    [Abstract] [Full Text] [Related]

  • 8. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jan; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D, Del Carmen Rial M, Vitko S, del Castillo D, Manas D, Lao M, Gafner N, Wijngaard P, Cyclosporine Withdrawal Study Group.
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [Abstract] [Full Text] [Related]

  • 10. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
    Wang J, Song X, Zhang W, Tong S, Hou J, Chen L, Lou J, Li H, Ding X, Min B.
    Zhonghua Yi Xue Za Zhi; 2002 Apr 25; 82(8):507-10. PubMed ID: 12133492
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct 25; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

  • 12. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 25; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 13. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
    Buell C, Koo J.
    J Drugs Dermatol; 2008 Aug 25; 7(8):741-8. PubMed ID: 18720690
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis.
    Daudén E, Pedraz J, Alvarez-Ruiz S, García-Río I, Sánchez-Peinado C, Oñate MJ, García-Diez A.
    Eur J Dermatol; 2010 Aug 25; 20(3):321-2. PubMed ID: 20146966
    [Abstract] [Full Text] [Related]

  • 15. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
    Davison SC, Morris-Jones R, Powles AV, Fry L.
    Br J Dermatol; 2000 Aug 25; 143(2):405-7. PubMed ID: 10951153
    [Abstract] [Full Text] [Related]

  • 16. Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.
    Thaçi D, Bräutigam M, Kaufmann R, Weidinger G, Paul C, Christophers E.
    Dermatology; 2002 Aug 25; 205(4):383-8. PubMed ID: 12444336
    [Abstract] [Full Text] [Related]

  • 17. Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
    Gottlieb AB, Griffiths CE, Ho VC, Lahfa M, Mrowietz U, Murrell DF, Ortonne JP, Todd G, Cherill R, Marks I, Emady-Azar S, Paul CF, Multi-Centre Investigator Group.
    Br J Dermatol; 2005 Jun 25; 152(6):1219-27. PubMed ID: 15948985
    [Abstract] [Full Text] [Related]

  • 18. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
    Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA.
    Br J Dermatol; 1998 Jan 25; 138(1):179-81. PubMed ID: 9536244
    [Abstract] [Full Text] [Related]

  • 19. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
    Vena GA, Galluccio A, Pezza M, Vestita M, Cassano N.
    J Dermatolog Treat; 2012 Aug 25; 23(4):255-60. PubMed ID: 21756153
    [Abstract] [Full Text] [Related]

  • 20. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.